Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet function in patients with high platelet counts.

A D Ginsburg

    Annals of Internal Medicine
    |April 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Platelet function tests can help differentiate myeloproliferative disorders from secondary thrombocytosis. Abnormal platelet aggregation is common in myeloproliferative disorders but rare in secondary thrombocytosis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Iron therapy.

    Canadian family physician Medecin de famille canadien·2011
    Same author

    Doxorubicin-induced cardiomyopathy.

    The New England journal of medicine·1999
    Same author

    Do doctors know when their patients don't? A survey of doctor-patient communication in lung cancer.

    Lung cancer (Amsterdam, Netherlands)·1997
    Same author

    Psychiatric illness and psychosocial concerns of patients with newly diagnosed lung cancer.

    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·1995
    Same author

    Porphyria cutanea tarda due to ferrous gluconate.

    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·1990
    Same author

    Systemic adjuvant therapy for node-negative breast cancer.

    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·1989
    Same journal

    The Role of Telemedicine on Interhospital Transfer Outcomes : A Systematic Review.

    Annals of internal medicine·2026
    Same journal

    Prolonged Short Sleep and Its Effect on Body Weight and Composition : A Pooled Analysis of Randomized Trials.

    Annals of internal medicine·2026
    Same journal

    In AF, LAAC was noninferior to NOAC therapy for a composite efficacy outcome and reduced non-procedure-related bleeding at 3 y.

    Annals of internal medicine·2026
    Same journal

    How AI is affecting medical journals.

    Annals of internal medicine·2026
    Same journal

    In adults with COPD, the BLISS score predicted risk for acute respiratory hospital admission at 2 y.

    Annals of internal medicine·2026
    Same journal

    In AF at risk for stroke and bleeding, LAAC was not noninferior to medical therapy for a composite of thromboembolic and safety events.

    Annals of internal medicine·2026
    See all related articles

    Area of Science:

    • Hematology
    • Oncology

    Background:

    • Elevated platelet counts (thrombocytosis) can indicate myeloproliferative disorders or secondary conditions.
    • Distinguishing between these conditions is crucial for appropriate patient management.

    Purpose of the Study:

    • To evaluate the diagnostic utility of platelet function tests in differentiating myeloproliferative disorders from secondary thrombocytosis.
    • To assess specific platelet function parameters for discriminatory significance.

    Main Methods:

    • Platelet aggregation studies were performed.
    • Bleeding time and platelet factor 3 activity were measured.
    • Platelet function was assessed in patients with polycythaemia vera, essential thrombocythaemia, secondary thrombocytosis, and chronic myeloid leukaemia.

    Related Experiment Videos

    Main Results:

    • Significant platelet aggregation abnormalities were observed in most patients with polycythaemia vera and essential thrombocythaemia.
    • Defective platelet aggregation was uncommon in patients with secondary thrombocytosis.
    • Bleeding time and platelet factor 3 activity showed some discriminatory value but with considerable overlap.
    • Platelet function was largely normal in patients with chronic myeloid leukaemia.

    Conclusions:

    • Platelet function tests, particularly aggregation studies, can aid in differentiating myeloproliferative neoplasms from reactive thrombocytosis.
    • While bleeding time and platelet factor 3 activity offer some insights, they exhibit overlap, making them less definitive.
    • Further investigation into specific platelet function markers may refine diagnostic accuracy.